Related references
Note: Only part of the references are listed.PAK signalling during the development and progression of cancer
Maria Radu et al.
NATURE REVIEWS CANCER (2014)
The Rac GTPase effector p21-activated kinase is essential for hematopoietic stem/progenitor cell migration and engraftment
Adrienne M. Dorrance et al.
BLOOD (2013)
Pak2 Kinase Restrains Mast Cell FcεRI Receptor Signaling through Modulation of Rho Protein Guanine Nucleotide Exchange Factor (GEF) Activity
Rachelle Kosoff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk
Karl Staser et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Mouse hematopoietic cell-targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging-like phenotype
Charlie Mantel et al.
BLOOD (2012)
P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth
Hong He et al.
CANCER LETTERS (2012)
p21-activated Kinase-1 Signaling Regulates Transcription of Tissue Factor and Tissue Factor Pathway Inhibitor
Beatriz Sanchez-Solana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis
Hal E. Broxmeyer et al.
NATURE MEDICINE (2012)
R-Ras and Rac GTPase Cross-talk Regulates Hematopoietic Progenitor Cell Migration, Homing, and Mobilization
Xun Shang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Fanconi Anemia D2 Protein Is an Apoptotic Target Mediated by Caspases
Su-Jung Park et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
ATP11C is critical for the internalization of phosphatidylserine and differentiation of B lymphocytes
Mehmet Yabas et al.
NATURE IMMUNOLOGY (2011)
On how Rac controls hematopoietic stem cell activity
J. A. Cancelas
TRANSFUSION (2011)
Congenic interval of CD45/Ly-5 congenic mice contains multiple genes that may influence hematopoietic stem cell engraftment
Amanda Waterstrat et al.
BLOOD (2010)
Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo
Amitava Sengupta et al.
BLOOD (2010)
PAK as a therapeutic target in gastric cancer
Xiaodong Li et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion
Michelle K. Y. Siu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics
Jayme D. Allen et al.
BLOOD (2009)
Pak protein kinases and their role in cancer
Bettina Dummler et al.
CANCER AND METASTASIS REVIEWS (2009)
PAK1 and PAK2 have different roles in HGF-induced morphological responses
Michael D. Bright et al.
CELLULAR SIGNALLING (2009)
PAK signaling in oncogenesis
P. R. Molli et al.
ONCOGENE (2009)
PAK1 interacts with β-catenin and is required for the regulation of the β-catenin signalling pathway by gastrins
Hong He et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells
Yue Si et al.
BLOOD (2008)
Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells
Andrew S. McDaniel et al.
BLOOD (2008)
An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase
Sean W. Deacon et al.
CHEMISTRY & BIOLOGY (2008)
Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms
Salvatore J. Coniglio et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia
P. D. Emanuel
LEUKEMIA (2008)
2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase
Leonardo M. Porchia et al.
MOLECULAR PHARMACOLOGY (2007)
Transcription factors in myeloid development: balancing differentiation with transformation
Frank Rosenbauer et al.
NATURE REVIEWS IMMUNOLOGY (2007)
SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells
MJ Kiel et al.
CELL (2005)
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
HE Broxmeyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells
E Passegué et al.
CELL (2004)
Pak-1 expression increases with progression of colorectal carcinomas to metastasis
JH Carter et al.
CLINICAL CANCER RESEARCH (2004)
Genomic alterations in blastic natural killer/extranodal natural killer-like T cell lymphoma with cutaneous involvement
X Mao et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
The K252a derivatives, inhibitors for the PAK/MLK kinase family, selectively block the growth of RAS transformants
TV Nheu et al.
CANCER JOURNAL (2002)
Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients
A Jetmore et al.
BLOOD (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
C-Myc is a critical target for C/EBPα in granulopoiesis
LM Johansen et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking JunB expression in the myeloid lineage
E Passegué et al.
CELL (2001)
Regulation of STAT3 by direct binding to the Rac1 GTPase
AR Simon et al.
SCIENCE (2000)
Share Paper
